|
1
|
Xu N and Dahlback B: A novel human
apolipoprotein (apoM). J Biol Chem. 274:3117–31290. 1999.
View Article : Google Scholar
|
|
2
|
Luo G, Zhang X, Mu Q, Chen L, Zheng L, Wei
J, Berggren-Soderlund M, Nilsson-Ehle P and Xu N: Expression and
localization of apolipoprotein M in human colorectal tissues.
Lipids Health Dis. 9:1022010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feng YH, Zheng L, Wei J, Yu MM, Zhang J,
Luo GH and Xu N: Increased apolipoprotein M induced by lack of
scavenger receptor BI is not activated via HDL-mediated cholesterol
uptake in hepatocytes. Lipids Health Dis. 17:2002018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wei J, Yu Y, Feng Y, Zhang J, Jiang Q,
Zheng L, Zhang X, Xu N and Luo G: Negative correlation between
serum levels of homocysteine and apolipoprotein M. Curr Mol Med.
19:120–126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li T, Yang L, Zhao S and Zhang S:
Correlation between apolipoprotein M and inflammatory factors in
obese patients. Med Sci Monit. 24:5698–5703. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo G, Shi Y, Zhang J, Mu Q, Qin L, Zheng
L, Feng Y, Berggren-Söderlund M, Nilsson-Ehle P, Zhang X and Xu N:
Palmitic acid suppresses apolipoprotein M gene expression via the
pathway of PPARβ/δ in HepG2 cells. Biochem Biophys Res Commun.
445:203–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren K, Tang ZL, Jiang Y, Tan YM and Yi GH:
Apolipoprotein M. Clin Chim Acta. 446:21–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao JJ, Hu YW, Wang YC, Sha YH, Ma X, Li
SF, Zhao JY, Lu JB, Huang C, Zhao JJ, et al: ApoM suppresses
TNF-α-induced expression of ICAM-1 and VCAM-1 through inhibiting
the activity of NF-κB. DNA Cell Biol. 34:550–556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang XS, Zhao SP, Hu M and Luo YP:
Apolipoprotein M likely extends its anti-atherogenesis via
anti-inflammation. Med Hypotheses. 69:136–140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Luo G, Feng Y, Zheng L, Liu H,
Liang Y, Liu Z, Shao P, Berggren-Söderlund M, Zhang X and Xu N:
Decreased splenic CD4(+) T-lymphocytes in apolipoprotein M gene
deficient mice. Biomed Res Int. 2015:2935122015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu B, Luo GH, Feng YH, Yu MM, Zhang J,
Wei J, Yang C, Xu N and Zhang XY: Apolipoprotein M protects against
lipopolysaccharide-induced acute lung injury via
sphingosine-1-phosphate signaling. Inflammation. 41:643–653. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Frej C, Mendez AJ, Ruiz M, Castillo M,
Hughes TA, Dahlbäck B and Goldberg RB: A shift in ApoM/S1P between
HDL-particles in women with type 1 diabetes mellitus is associated
with impaired anti-inflammatory effects of the ApoM/S1P complex.
Arterioscler Thromb Vasc Biol. 37:1194–1205. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruiz M, Frej C, Holmer A, Guo LJ, Tran S
and Dahlbäck B: High-density lipoprotein-associated apolipoprotein
M limits endothelial inflammation by delivering
sphingosine-1-phosphate to the sphingosine-1-phosphate receptor 1.
Arterioscler Thromb Vasc Biol. 37:118–129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun SC: The non-canonical NF-κB pathway in
immunity and inflammation. Nat Rev Immunol. 17:545–558. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
King KE, George AL, Sakakibara N, Mahmood
K, Moses MA and Weinberg WC: Intersection of the p63 and NF-κB
pathways in epithelial homeostasis and disease. Mol Carcinog.
58:1571–1580. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen KY and Wang LC: Stimulation of IL-1β
and IL-6 through NF-κB and sonic hedgehog-dependent pathways in
mouse astrocytes by excretory/secretory products of fifth-stage
larval angiostrongylus cantonensis. Parasit Vectors. 10:4452017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nonaka K, Kajiura Y, Bando M, Sakamoto E,
Inagaki Y, Lew JH, Naruishi K, Ikuta T, Yoshida K, Kobayashi T, et
al: Advanced glycation end-products increase IL-6 and ICAM-1
expression via RAGE, MAPK and NF-κB pathways in human gingival
fibroblasts. J Periodontal Res. 53:334–344. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Conti P, Kempuraj D, Kandere K, Di
Gioacchino M, Barbacane RC, Castellani ML, Felaco M, Boucher W,
Letourneau R and Theoharides TC: IL-10, an inflammatory/inhibitory
cytokine, but not always. Immunol Lett. 86:123–129. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song X, Ren Z and Zhang C: Antioxidant,
anti-inflammatory and renoprotective effects of acidic-hydrolytic
polysaccharides by spent mushroom compost (Lentinula edodes)
on LPS-induced kindey injury. Int J Biol Macromol. 151:1267–1276.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Lu Z, Yun L, Li P, Jun Z, Jiang W,
Miao M and Guang L: Establishment of real-time quantitative PCR
method for identification of apolipoprotein M knockout mice. Chin J
Clin Lab Sci. 33:32015.
|
|
21
|
Wu BM, Liu JD, Li YH and Li J: Margatoxin
mitigates CCl4induced hepatic fibrosis in mice via macrophage
polarization, cytokine secretion and STAT signaling. Int J Mol Med.
45:103–114. 2020.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kuprash DV and Nedospasov SA: Molecular
and cellular mechanisms of inflammation. Biochemistry (Mosc).
81:1237–1239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen B, Ma Y, Xue X, Wei J, Hu G and Lin
Y: Tetramethylpyrazine reduces inflammation in the livers of mice
fed a high fat diet. Mol Med Rep. 19:2561–2568. 2019.PubMed/NCBI
|
|
25
|
Sayers SR, Beavil RL, Fine NHF, Huang GC,
Choudhary P, Pacholarz KJ, Barran PE, Butterworth S, Mills CE,
Cruickshank JK, et al: Structure-functional changes in eNAMPT at
high concentrations mediate mouse and human beta cell dysfunction
in type 2 diabetes. Diabetologia. 63:313–323. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lassailly G, Bou Saleh M, Leleu-Chavain N,
Ningarhari M, Gantier E, Carpentier R, Artru F, Gnemmi V, Bertin B,
Maboudou P, et al: Nucleotide-binding oligomerization domain 1
(NOD1) modulates liver ischemia reperfusion through the expression
adhesion molecules. J Hepatol. 70:1159–1169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wolfrum C, Poy MN and Stoffel M:
Apolipoprotein M is required for prebeta-HDL formation and
cholesterol efflux to HDL and protects against atherosclerosis. Nat
Med. 11:418–422. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adib-Conquy M and Cavaillon JM: Host
inflammatory and anti-inflammatory response during sepsis. Pathol
Biol (Paris). 60:306–313. 2012.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scheller J, Chalaris A, Schmidt-Arras D
and Rose-John S: The pro- and anti-inflammatory properties of the
cytokine interleukin-6. Biochim Biophys Acta. 1813:878–888. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iyer SS and Cheng G: Role of interleukin
10 transcriptional regulation in inflammation and autoimmune
disease. Crit Rev Immunol. 32:23–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baeck C and Tacke F: Balance of
inflammatory pathways and interplay of immune cells in the liver
during homeostasis and injury. EXCLI J. 13:67–81. 2014.PubMed/NCBI
|
|
32
|
Ben-Neriah Y and Karin M: Inflammation
meets cancer, with NF-κB as the matchmaker. Nat Immunol.
12:715–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma X, Hu YW, Zhao ZL, Zheng L, Qiu YR,
Huang JL, Wu XJ, Mao XR, Yang J, Zhao JY, et al: Anti-inflammatory
effects of propofol are mediated by apolipoprotein M in a
hepatocyte nuclear factor-1α-dependent manner. Arch Biochem
Biophys. 533:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Galvani S, Sanson M, Blaho VA, Swendeman
SL, Obinata H, Conger H, Dahlbäck B, Kono M, Proia RL, Smith JD and
Hla T: HDL-bound sphingosine 1-phosphate acts as a biased agonist
for the endothelial cell receptor S1P1 to limit vascular
inflammation. Sci Signal. 8:ra792015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng Z, Zeng Y, Zhu X, Tan Y, Li Y, Li Q
and Yi G: ApoM-S1P modulates Ox-LDL-induced inflammation through
the PI3K/Akt signaling pathway in HUVECs. Inflammation. 42:606–617.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mierzejewska P, Zabielska MA, Kutryb-Zajac
B, Tomczyk M, Koszalka P, Smolenski RT and Slominska EM: Impaired
L-arginine metabolism marks endothelial dysfunction in
CD73-deficient mice. Mol Cell Biochem. 458:133–142. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li F, Zhang T, He Y, Gu W, Yang X, Zhao R
and Yu J: Inflammation inhibition and gut microbiota regulation by
TSG to combat atherosclerosis in ApoE(−/-) mice. J Ethnopharmacol.
247:1122322020. View Article : Google Scholar : PubMed/NCBI
|
